HIV

FDA Torpedoes CytoDyn's Leronlimab for COVID-19 with Rare Public Scolding
BioSpace
Tue, 05/18/21 - 11:08 pm
FDA
leronlimab
CytoDyn
HIV
cancer
monoclonal antibodies
ViiV begins rolling submission for cabotegravir to prevent HIV in US
Pharmaceutical Business Review
Wed, 05/5/21 - 10:31 am
ViiV Healthcare
cabotegravir
HIV
FDA
GSK's ViiV Healthcare continues cabaret campaign to engage and inspire HIV community
Fierce Pharma
Thu, 04/8/21 - 07:35 pm
pharma marketing
GSK
ViiV Healthcare
HIV
How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market
Motley Fool
Thu, 03/25/21 - 11:46 am
Gilead Sciences
Merck
HIV
drug development
Gilead, Merck combine forces in HIV
BioPharma Dive
Mon, 03/15/21 - 11:51 pm
Gilead Sciences
Merck
HIV
Aelix posts HIV vaccine data ahead of Gilead combo readout
Fierce Biotech
Thu, 03/11/21 - 10:37 am
Aelix Therapeutics
HIV
vaccines
Gilead Sciences
Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression
Endpoints
Mon, 03/8/21 - 11:04 am
Gilead Sciences
Biktarvy
HIV
Exclusive: After four decades, one researcher's radical HIV cure finally gets its shot
Endpoints
Wed, 02/17/21 - 10:45 am
Kamel Khalili
HIV
Excision BioTherapeutics
Incyte makes bid to join the checkpoint inhibitor club
Pharmaforum
Tue, 02/2/21 - 10:25 am
Incyte
FDA
retifanlimab
anal cancer
HIV
HPV
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
BioPharma Dive
Mon, 02/1/21 - 10:48 am
Gilead Sciences
HIV
Gritstone Oncology
drug development
FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo
RAPS.org
Thu, 01/28/21 - 10:49 am
FDA
Cabenuva
HIV
ViiV
Aurinia
Lupkynis
Merck
Verquvo
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
Sun, 01/24/21 - 03:24 pm
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
FDA approves first monthly injectable to treat HIV infection
Stat
Thu, 01/21/21 - 11:45 pm
ViiV
FDA
Cabenuva
HIV
Fierce Pharma's top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches
Fierce Pharma
Wed, 12/23/20 - 10:51 am
pharma marketing
drug pricing
COVID-19
pandemic
remdesivir
Gilead Sciences
HIV
PrEP
Pfizer
Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir
Pharmaforum
Thu, 11/19/20 - 10:18 am
Gilead Sciences
lenacapavir
HIV
GSK and ViiV score breakthrough therapy designation in HIV prevention, as Truvada showdown draws nearer
Endpoints
Tue, 11/17/20 - 11:12 pm
GSK
ViiV
FDA
cabotegravir
HIV
PrEP
GSK’s ViiV Healthcare caps virtual HIV summit with a Facebook Live cabaret
Fierce Pharma
Sat, 11/14/20 - 09:56 pm
GSK
ViiV
HIV
Facebook
drug marketing
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
Endpoints
Mon, 11/9/20 - 11:56 am
GSK
ViiV
cabotegravir
HIV
PrEP
FDA
Gilead announces new data on Biktarvy for the treatment of HIV in Black Americans
Pharmaceutical Business Review
Thu, 10/22/20 - 11:04 am
Gilead Sciences
Biktarvy
HIV
GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen
Fierce Pharma
Mon, 10/5/20 - 11:45 am
GSK
ViiV
Dovato
HIV

Pages